Concepts (37)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 2 | 2024 | 507 | 1.050 |
Why?
|
| Deoxycytidine | 1 | 2024 | 63 | 0.910 |
Why?
|
| Neuroendocrine Tumors | 1 | 2019 | 29 | 0.650 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 130 | 0.620 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2024 | 46 | 0.230 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 284 | 0.190 |
Why?
|
| Cholangiocarcinoma | 1 | 2021 | 5 | 0.190 |
Why?
|
| Serotonin | 1 | 2021 | 16 | 0.190 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2021 | 14 | 0.180 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2021 | 25 | 0.180 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2020 | 27 | 0.170 |
Why?
|
| Neovascularization, Pathologic | 1 | 2021 | 144 | 0.170 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 1927 | 0.160 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 213 | 0.160 |
Why?
|
| Databases, Factual | 1 | 2019 | 250 | 0.150 |
Why?
|
| Humans | 4 | 2024 | 26827 | 0.140 |
Why?
|
| Male | 2 | 2024 | 12870 | 0.140 |
Why?
|
| Prospective Studies | 1 | 2019 | 1217 | 0.130 |
Why?
|
| Female | 2 | 2024 | 14463 | 0.130 |
Why?
|
| Signal Transduction | 1 | 2021 | 1344 | 0.120 |
Why?
|
| Aged | 1 | 2024 | 5167 | 0.120 |
Why?
|
| United States | 1 | 2020 | 2033 | 0.110 |
Why?
|
| Treatment Outcome | 1 | 2020 | 2264 | 0.110 |
Why?
|
| Retrospective Studies | 1 | 2020 | 2433 | 0.110 |
Why?
|
| Middle Aged | 1 | 2024 | 6818 | 0.110 |
Why?
|
| Adult | 1 | 2020 | 7383 | 0.070 |
Why?
|
| Serotonin Antagonists | 1 | 2021 | 2 | 0.050 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2021 | 2 | 0.050 |
Why?
|
| Receptors, Serotonin | 1 | 2021 | 4 | 0.050 |
Why?
|
| Octreotide | 1 | 2021 | 4 | 0.050 |
Why?
|
| Phenylalanine | 1 | 2021 | 23 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 310 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2021 | 121 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 124 | 0.040 |
Why?
|
| Cell Movement | 1 | 2021 | 353 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 444 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2021 | 771 | 0.040 |
Why?
|